Glycyl-glutamine

Glycyl-glutamine (Glycyl-L-glutamine), as a enzymatic cleavage product of β-endorphin, is apparently an endogenous antagonist of beta-endorphin (1-31) in several systems[1]. Glycyl-glutamine (Glycyl-L-glutamine) is an activate and stable glutamine-containing neuropeptide over glutamine (Gln) [2].

Product Specifications

CAS Number

[13115-71-4]

Product Name Alternative

Glycyl-L-glutamine

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/glycyl-glutamine.html

Purity

98.0

Solubility

H2O : 58.33 mg/mL (ultrasonic)

Smiles

O=C([C@H](CCC(N)=O)NC(CN)=O)O

Molecular Formula

C7H13N3O4

Molecular Weight

203.20

Precautions

H302, H315, H319, H335

References & Citations

[1]Unal CB1, et al. Beta-endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine, a dipeptide derived from beta-endorphin processing.J Pharmacol Exp Ther. 1994 Nov;271 (2) :952-8|[2]Roth E, et al. Influence of two glutamine-containing dipeptides on growth of mammalian cells.In Vitro Cell Dev Biol. 1988 Jul;24 (7) :696-8.